Bill Commons

TN HB 1239

enacted

Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Tennessee · 114S1 · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did TN HB 1239 pass?

Yes. TN HB 1239 has been enacted into law. Latest recorded action (2025-04-28): Pub. Ch. 295

What is TN HB 1239 about?

TN HB 1239 is a bill in the 114S1 titled “Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.”.

Who sponsors TN HB 1239?

Helton-Haynes is the primary sponsor of TN HB 1239.

Introduced
2025-02-10
Latest action
2025-04-28 — Pub. Ch. 295
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Helton-Haynesprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2025-04-28

    Pub. Ch. 295

  2. 2025-04-28

    Effective date(s) 07/01/2025

  3. 2025-04-24

    Signed by Governor.

    executive-signature

  4. 2025-04-16

    Transmitted to Governor for his action.

    executive-receipt

  5. 2025-04-14

    Signed by Senate Speaker

    passage

  6. 2025-04-10

    Signed by H. Speaker

    passage

  7. 2025-04-08

    Enrolled; ready for sig. of H. Speaker.

    enrolled

  8. 2025-04-07

    H. adopted am. (Amendment 1 - HA0252)

    amendment-passage

  9. 2025-04-07

    Sponsor(s) Added.

    sponsorship

  10. 2025-04-07

    Passed H., as am., Ayes 92, Nays 1, PNV 0

    passage

  11. 2025-04-07

    Engrossed; ready for transmission to Sen.

    receipt

  12. 2025-04-07

    Received from House, Passed on First Consideration

    introduction

  13. 2025-04-07

    Senate substituted House Bill for companion Senate Bill.

    substitution

  14. 2025-04-07

    Amendment withdrawn. (Amendment 1 - SA0095)

  15. 2025-04-07

    Passed Senate, Ayes 27, Nays 4

    passage

  16. 2025-04-03

    H. Placed on Regular Calendar for 4/7/2025

  17. 2025-04-02

    Placed on cal. Calendar & Rules Committee for 4/3/2025

  18. 2025-04-01

    Rec. for pass. if am., ref. to Calendar & Rules Committee

    committee-passage-favorable

  19. 2025-03-26

    Placed on cal. Health Committee for 4/1/2025

  20. 2025-03-25

    Action def. in Health Committee to 4/1/2025

  21. 2025-03-19

    Rec for pass if am by s/c ref. to Health Committee

    referral-committee

  22. 2025-03-19

    Placed on cal. Health Committee for 3/25/2025

  23. 2025-03-12

    Placed on s/c cal Health Subcommittee for 3/19/2025

  24. 2025-02-12

    P2C, ref. to Health Committee

    referral-committee

  25. 2025-02-12

    Assigned to s/c Health Subcommittee

    referral-committee

  26. 2025-02-10

    Intro., P1C.

    introduction

  27. 2025-02-06

    Filed for introduction

    filing

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-10-29T01:27:43.100688Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TN&identifier=HB 1239. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.